Amoval

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amoval

Property Description
Active ingredient Amoxicillin
Form Capsule, tablet, oral suspension
Pharmacological class beta-Lactam antibiotic (Aminopenicillin)
Common use Control of bacterial infections
Origin Semi-synthetic

Amoval: Classification, Identity, and Core Composition

Amoval is a trade name for a medicine containing the active ingredient Amoxicillin, which is classified as an aminopenicillin within the beta-Lactam antibiotic family. Amoxicillin itself is a semi-synthetic compound, chemically derived from the core penicillin structure to improve its efficacy and oral absorption. The medicine is most commonly prepared using Amoxicillin trihydrate, the form often preferred by manufacturers. Amoxicillin is widely recognized for its broad-spectrum activity, which differentiates it from narrow-spectrum penicillins. The medicine is supplied in various pharmaceutical dosage forms, including solid capsule and tablet presentations, as well as powder for oral suspension to create a liquid form for pediatric patients. Amoxicillin is considered one of the most widely used antibiotics due to its effectiveness against a range of microbial organisms.


General Purpose and Mechanism of Amoxicillin

The general therapeutic purpose of Amoxicillin is the control and resolution of infections caused by susceptible bacteria. Amoxicillin functions as a bactericidal agent, meaning its purpose is to directly kill the target bacteria rather than merely inhibiting their growth. This definitive action is accomplished through the specific inhibition of bacterial cell wall synthesis, fundamentally disrupting the microbial structure and leading to the microbe's destruction. Amoxicillin is effective for fighting off a broad range of Gram-positive and Gram-negative bacteria, making it a significant agent in clinical use. As a result, the general benefit of Amoxicillin stems from its capacity to eliminate a wide array of bacterial pathogens, addressing the core cause of microbial disease, such as in typical scenarios involving common respiratory infections.

Regulatory References

  1. Amoxicillin on WHO Essential Medicines List

What side effects are possible with Amoval?

Possible Side Effects and Safety Information

The official safety profile for Amoval, which contains the aminopenicillin Amoxicillin, is structured by classifying possible effects according to their frequency and the body system affected. Regulatory documents classify common adverse reactions, defined as occurring in 1% to 10% of users, which primarily affect the Gastrointestinal disorders (diarrhea, nausea, vomiting) and the Skin and Subcutaneous Tissue disorders (rash).


Documented Serious Adverse Reactions

The most significant, though rare, safety concerns are explicitly highlighted in regulatory texts as Serious Adverse Reactions. These include severe, potentially fatal allergic reactions like Anaphylaxis and severe skin conditions known as SCARs (Severe Cutaneous Adverse Reactions), such as Stevens-Johnson Syndrome (SJS). The medicine is also associated with Clostridioides difficile-Associated Diarrhea (CDAD) and liver injury (Hepatitis/Cholestatic Jaundice), which can sometimes manifest several weeks after treatment has stopped.


Population-Specific and Contextual Safety Notes

Official safety documents detail specific considerations for certain populations. Patients with infectious mononucleosis have a significantly increased risk of developing a generalized skin rash with Amoxicillin use. Due to the medicine's kidney-based elimination, caution is advised for geriatric patients and those with renal impairment. Furthermore, a history of penicillin hypersensitivity is noted as increasing the likelihood of serious allergic reactions. Certain side effects, such as CDAD, have been documented to appear up to two months after the medicine is discontinued, highlighting that some risks are not limited to the active treatment period.

Overdose and Emergency Response

Overdose and when to seek help

Officially documented manifestations of Amoval (Amoxicillin) overdose primarily involve gastrointestinal effects, including nausea, vomiting, and diarrhea. The regulatory profile also notes the potential for Central Nervous System (CNS) effects, such as confusion and the specific risk of convulsions (seizures). A severe skin rash may also be noted.

A key documented complication in overexposure or high-dose administration is amoxicillin crystalluria, where crystals form in the urine, potentially leading to decreased urination or acute renal injury. Regulatory information specifies that patients with pre-existing impaired renal function are at an elevated risk for developing CNS effects, including convulsions.

Management is symptomatic and supportive, as no specific antidote is known. Haemodialysis is documented as a procedure that can remove the drug from circulation. Supportive measures explicitly require maintaining adequate fluid intake and urinary output to mitigate the risk of crystal formation.

Immediate Medical Attention Required:

Emergency medical care must be sought immediately upon suspicion of overdose. Official health guidance mandates calling emergency services for immediate life-threatening symptoms, such as collapse, seizure, trouble breathing, or inability to be awakened. Contacting a poison control center is also a required action in all cases of suspected overexposure.

Therapeutic Uses of Amoval

What Amoval Treats: Main Uses and Benefits

Amoval is commonly used to help with symptom clusters that may become intense or disruptive in conditions presenting with systemic or localized discomfort. The medication is relevant in conditions characterized by periods of heightened symptoms across key therapeutic areas.


Easing Discomfort from Bacterial Infections

This medication is applied across domains where additional symptomatic support is needed to address infections affecting the ears, throat, sinuses, and lower respiratory tract, as well as the skin, urinary tract, and oral cavity. Specifically, Amoval is used for managing conditions such as acute otitis media, tonsillitis, bacterial sinusitis, bronchitis, pneumonia, cellulitis, UTIs, and dental abscesses. This therapeutic use may assist with managing pronounced symptomatic discomfort, such as fever, pain, and localized swelling. It contributes to easing the overall symptom load during the acute phase of illness, helping patients cope more steadily with symptom fluctuations.

Specialized Therapeutic Scenarios

Amoval is relevant in contexts marked by increased discomfort or tension from specialized infections. It may be part of multi-drug regimens for H. pylori eradication, which may be part of symptomatic management in situations where patients experience recurrent or episodic manifestations. It is also used for infection prophylaxis to prevent potential systemic infections in specific high-risk scenarios, providing supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Localized Pain and Fever

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility for Amoval (Amoxicillin) Use

The eligibility for Amoval use is strictly defined by regulatory authorities, focusing on a patient's immunologic history and physiological status.

Absolute Contraindications

Amoval is contraindicated and must not be used by individuals with a documented history of hypersensitivity or allergic reactions to any penicillin or any other beta-Lactam antibiotic (such as cephalosporins).

Restricted and Conditional Use

  • Conditions Affecting Use: The medicine is generally not recommended for patients with infectious mononucleosis or lymphatic leukemia due to an elevated risk of developing a non-allergic skin rash.
  • Organ Function: Patients with severe renal impairment (kidney dysfunction) require a mandated dose reduction to prevent accumulation of the medicine in the body, making their use conditional.
  • Metabolic Restrictions: Specific formulations, such as oral suspensions, are restricted for patients with phenylketonuria (PKU) if they contain phenylalanine.

Age and Reproductive Status

Use is established across all major age groups, including adults, older adults, and pediatric patients over three months of age. For infants under three months, use is permitted but requires specialized dose monitoring. Regarding pregnancy, Amoxicillin is commonly classified as Category B and is considered acceptable when clinically necessary; caution is advised during lactation due to its presence in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe specific interaction patterns for Amoval (Amoxicillin) involving pharmacokinetic and pharmacodynamic mechanisms, strictly defining how the medicine may affect or be affected by certain co-administered substances.

Documented Interaction Patterns

Interacting Substance Official Regulatory Outcome
Probenecid (Uricosuric agent) Decreases the renal tubular secretion of Amoxicillin, officially resulting in increased and prolonged blood levels of the antibiotic. This is a pharmacokinetic interaction.
Oral Anticoagulants (e.g., Warfarin) May lead to an increased prolongation of prothrombin time (INR), officially documented as an increased risk of bleeding. This is a pharmacodynamic effect.
Bacteriostatic Antibacterials May interfere with the bactericidal effect of Amoxicillin, as noted in official prescribing information.
Oral Contraceptives Official labeling states that co-administration may reduce the efficacy of these hormonal products.
Allopurinol Concurrent use is officially documented to increase the incidence of skin rash.

Administration Context Constraints

The extended-release tablet formulation has a specific regulatory constraint and must be taken within one hour after a meal. For patients with impaired renal function, clearance is reduced; this leads to high Amoxicillin blood levels that can be exacerbated by interacting substances like Probenecid, requiring attention to documented exposure-modifying effects.

Mechanism of Action

How Amoval Works

Amoval (Amoxicillin) acts through a highly specific mechanism focused entirely on disrupting the structural integrity of susceptible bacteria, resulting in their death.


Irreversible Inhibition of Cell Wall Synthesis

The drug functions as an irreversible covalent inhibitor of bacterial enzymes known as Penicillin-binding proteins ( PBPs). These PBPs are DD-transpeptidases essential for the final assembly of the bacterial cell wall structure. The drug's molecular structure mimics a natural building block, allowing it to deceive the enzyme and form a permanent bond at its active site, neutralizing its ability to catalyze the essential peptidoglycan cross-linking process.


Osmotic Disruption and Bactericidal Cascade

By preventing the construction of a robust, intact cell wall, the drug initiates a lethal cascade of osmotic disruption. The compromised microbial wall cannot withstand the high internal fluid pressure, leading to an immediate and uncontrolled influx of water, which rapidly causes bacterial cell lysis (rupture). This definitive mechanism is classified as bactericidal because it results in the direct and complete destruction of the target microbe, an effect most active against bacteria that are actively growing and dividing.


Mechanistic Limitations by Bacterial Defenses

The functional scope of this mechanism is constrained by bacterial counter-mechanisms, primarily the production of beta-Lactamase enzymes. These enzymes physically destroy the drug's active beta-lactam ring before it can reach the PBP target. The mechanism is also inherently less active against bacteria that have structurally altered PBPs or those that are in a dormant state, as their lack of active cell wall construction bypasses the drug's target process.

Dosage and Administration Information

How to Use Amoval (Amoxicillin) — Official Administration Guidelines

Amoval (Amoxicillin) must be used strictly according to the official instructions to ensure proper systemic exposure and course completion.

Administration Scope

Instruction Detail
Route of Administration Primarily Oral (capsules, tablets, liquid suspension) and Intravenous/Intramuscular for severe infections (active substance).
Timing in Relation to Meals May be taken with or without food, as absorption is not significantly impaired.
Preparation Requirements Oral Suspension powder must be reconstituted by adding the specified volume of water and shaking vigorously before use; liquid doses must be measured with a calibrated device.

Official Dosing and Scheduling

Population Standard Dosing Regimen (Examples)
Adults (ge 40 kg) 500 mg every 12 hours or 250 mg every 8 hours for mild to moderate infections. Severe infections typically require higher doses, such as 875 mg every 12 hours.
Pediatric Patients (< 40 kg) Dosing is weight-based (e.g., 20 to 45 mg/kg/day), divided and given every 8 or 12 hours. Infants under 3 months have a maximum limit of 30 mg/kg/day divided every 12 hours.
Renal Adjustment Dose reduction is required for severe renal impairment (Glomerular Filtration Rate < 30 mL/min). Patients with GFR < 10 mL/min should receive a maximum of 500 mg every 24 hours.

Procedural Directives

The full treatment duration for most infections is 10 to 14 days, but a minimum of 10 days is recommended for Streptococcus pyogenes to prevent acute rheumatic fever. If a dose is missed, take it as soon as remembered unless it is near the next scheduled dose, in which case the missed dose should be skipped to prevent doubling. Adequate fluid intake is advisable during high-dose therapy to reduce the possibility of crystalluria.

Recent Clinical Evidence

Amoval: Recent Clinical Evidence

Evaluation of Therapeutic Focus

Research has examined the Amoval combination drug in the context of treating acute non-specific musculoskeletal pain. The primary goal of the reviewed studies was to explore the potential outcomes of pain management.

Studies examined the effects of the active ingredients, with some data examining differences in the observed effect on pain intensity when compared to individual agents. Research has evaluated whether the combination was associated with patient-reported quality of life and function recovery time. Specific study endpoints included:

  • Pain Intensity: Early-phase studies and an RCT focused on the short-term impact on pain intensity, using the Visual Analogue Scale (VAS).
  • Functional Status: Secondary endpoints examined changes in daily activities and movement-related disability.
  • Onset of Effect: Studies evaluated the onset of observed effect within the first 24 hours of treatment.

Safety and Tolerability Profile

Tolerability was generally reported in the studied populations. The profile of adverse events (AEs) was generally consistent with the known AEs of the individual components.

Common AEs reported in the clinical trials included mild gastrointestinal upset, dizziness, and somnolence. These were generally transient and did not often lead to discontinuation of the study medication. The treatment duration evaluated in the reviewed studies was generally up to 7 days. Research subjects typically excluded individuals with pre-existing liver conditions.

Further research has characterized the action of this combination on physiological pathways. ADME (absorption, distribution, metabolism, and excretion) profiles were also characterized in the populations studied.

Key Studies & References

  1. Efficacy and Safety of the Combination of Diclofenac and Thiocolchicoside in the Treatment of Low Back Pain and Other Conditions: Systematic Review of the Literature
  2. Efficacy of Thiocolchicoside for Musculoskeletal Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (including safety restrictions)

Frequently Asked Questions (FAQ)

Common questions about Amoval (FAQ)

Q: How quickly should I expect Amoval to start reducing my infection symptoms?

A: According to official pharmacokinetic data, Amoval is rapidly absorbed after being taken by mouth, with the highest concentration in the blood typically reached within one to two hours. However, the exact time it takes for you to notice a reduction in your infection symptoms can vary depending on the type of infection and its severity.

Q: Is it true that Amoval should only be used for bacterial infections?

A: Yes, official labeling classifies Amoval as a penicillin-class antibacterial medicine. It is specified that the medicine should only be used to treat infections that are proven or strongly suspected to be caused by susceptible bacteria, and is not indicated for the treatment of viral infections, such as the common cold or flu.

Q: Can Amoval cause a yeast infection, and if so, why does this happen?

A: Regulatory documents report that fungal superinfections, such as vulvovaginal mycotic infection (a yeast infection) and candidiasis, can occur during therapy. This is described as a possible secondary infection resulting from the antibacterial activity of the medicine.

Q: What kind of skin rash should I watch for while taking Amoval?

A: Official labeling describes skin reactions ranging from common rashes and hives to rare, serious skin reactions known as severe cutaneous adverse reactions (SCARs). Serious reactions are highlighted separately and involve symptoms that necessitate immediate medical attention, such as Anaphylaxis or SCARs.

Q: What are the rare but serious side effects that Amoval drug labeling is required to list?

A: Serious adverse reactions highlighted in official safety documents include severe allergic reactions, such as Anaphylaxis. Other serious concerns listed are severe skin conditions (SCARs), liver injury (hepatitis/cholestatic jaundice), and Clostridioides difficile-Associated Diarrhea (CDAD).

Q: Is it possible for diarrhea to last for several weeks after finishing the Amoval treatment course?

A: Regulatory information notes that Clostridioides difficile-associated diarrhea (CDAD), which is a potentially severe infection, has been reported to occur more than two months after stopping antibacterial agents. Regulatory warnings indicate that severe or persistent diarrhea can sometimes manifest even after the medicine has been discontinued.

Q: How is Amoval classified regarding its use during pregnancy?

A: Amoval is designated as Pregnancy Category B in FDA labeling. This classification means that animal reproduction studies have generally not demonstrated a risk to the fetus, but adequate and well-controlled studies in pregnant women are not available.

Q: Is Amoval still effective if a dose is missed?

A: Official administration instructions emphasize taking the medicine as scheduled to maintain the intended therapeutic exposure levels. The full procedure for handling a missed dose is detailed in the 'How to Use Amoval' section.

Q: Does Amoval pass into breast milk, and what is the official guidance for breastfeeding mothers?

A: Penicillins, including Amoval, have been shown to be excreted in human milk. Regulatory documents advise that caution should be exercised when the medicine is administered to a nursing woman due to the presence of the medicine in breast milk.

Q: Does Amoval treat infections caused by viruses like the common cold or flu?

A: Official labeling specifies that Amoval is an antibacterial medicine and should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. It is not indicated for the treatment of viral infections, such as the common cold or flu.

Q: What does it mean for bacteria to become "resistant" to Amoval?

A: Official information describes resistance as a mechanism where bacteria develop ways to overcome the medicine. This often involves the production of specific bacterial enzymes that destroy the active structure of the Amoval molecule, preventing it from working.

Q: Is Amoval considered a broad-spectrum antibiotic?

A: Yes, Amoval is officially described in regulatory documents as having a broad spectrum of bactericidal activity. This means it acts against a wide variety of both Gram-positive and Gram-negative microorganisms.

Q: How common are side effects such as diarrhea, nausea, or vomiting with Amoval?

A: In clinical trials, the most commonly reported side effects, including diarrhea, nausea, and vomiting, were classified as common. This frequency means they were observed in more than 1% but less than 10% of patients who took the medicine.

Q: What is the difference between a simple skin reaction and a serious allergic rash from Amoval?

A: Official documents classify reactions by severity. Common rashes are generally listed as minor skin disorders, whereas severe, potentially life-threatening reactions such as anaphylaxis are listed separately under Warnings and Precautions. The official documentation advises seeking medical attention for any suspected serious allergic reaction.

Q: Can Amoval cause discoloration or staining of the teeth?

A: Tooth discoloration, which may appear as brown, yellow, or gray staining, has been reported in official documents, particularly with the liquid suspension form. This effect is often described as a superficial staining of the enamel that is typically reversible with brushing or professional dental cleaning.

Q: Can Amoval cause side effects that relate to liver function or jaundice?

A: Official regulatory documents list liver-related reactions as very rare side effects. These include reports of hepatitis (liver inflammation) and cholestatic jaundice (a condition causing the yellowing of the skin or eyes).

Q: Is Amoval known to cause dizziness or lightheadedness?

A: Dizziness is listed in the official documents as a possible adverse reaction. This effect is reported in the very rare frequency category, as described in official documents.

Q: Is a moderate stomach ache considered a normal side effect of Amoval?

A: Abdominal pain is listed as a common gastrointestinal side effect in official documents. In clinical trials, this side effect, along with diarrhea and nausea, was reported in 1% to 10% of patients.

Q: What is the risk of a severe rash if Amoval is taken by someone with mononucleosis ('mono')?

A: Regulatory documents advise against administering Amoval to patients with infectious mononucleosis. This is because official findings indicate that a high percentage of these patients develop an erythematous (reddish) skin rash.

Q: Does Amoval have any effect on a person's mood or cause difficulty sleeping?

A: Adverse reactions affecting the central nervous system have been noted in the official reports, typically in the very rare frequency category. These reactions may include sleeplessness (insomnia) or agitation.

Q: Are there any foods or drinks that should be strictly avoided while taking Amoval?

A: Official regulatory documents do not list any common foods or drinks that must be strictly avoided due to a known interaction with Amoval. The non-extended release formulations of the medicine may be taken with or without food.

Q: What is the recommendation for taking Amoval—with or without food?

A: Regulatory documents state that Amoval may be taken with or without food. This is because official studies have shown that the absorption of the medication is not significantly affected by meals.

Q: Can Amoval cause drowsiness or impair a person's ability to drive?

A: Adverse reactions affecting the central nervous system, such as dizziness or convulsions, have been reported as very rare events. If such very rare central nervous system effects are experienced, they may affect the ability to drive or operate machinery, according to regulatory documents.

Q: Why is the liquid form of Amoval sometimes associated with temporary tooth discoloration?

A: Official documents report that tooth discoloration, often seen with the liquid suspension, is typically a superficial staining of the enamel surface. This effect is usually reversible and often responds to brushing or professional dental cleaning.

Q: How long does Amoval typically stay in the body after the last dose is taken?

A: Regulatory pharmacokinetic data indicates that the half-life of Amoval is approximately one hour. Detectable blood levels of the medicine may be observed for up to eight hours after a single oral dose.

Q: Is there a difference in how the body uses Amoval capsules versus the liquid suspension?

A: Pharmacokinetic studies comparing different formulations show that the various oral forms, such as capsules, chewable tablets, and liquid suspensions, generally produce similar blood levels of the medicine when administered at corresponding doses.

How should Amoval be stored and disposed of?

Official Storage and Disposal Requirements

Amoval (amoxicillin) storage requirements vary based on the dosage form and are defined by regulatory labeling.

Dosage Form Storage Condition Stability/Handling Rule
Capsules/Tablets/Dry Powder Store at room temperature Keep container tightly closed and away from excess moisture.
Reconstituted Suspension Store in a refrigerator Must not be frozen; discard any unused portion after 14 days.

All forms must be stored out of the sight and reach of children. The preferred method for disposal of unused or expired Amoval is a drug take-back program. If unavailable, the medicine should be mixed with an undesirable substance (such as dirt) and placed in a sealed container in the household trash. The medication is not on the list of products recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoval found in:

A-Z Index: